Bronchitis - Asthma
- Manufacturer
- Newton Laboratories, Inc.
- Effective date
- 2011-06-01
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 1
- Source
- legacy-cache
- Hydrated at
- 2026-08-02 01:37:42
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
INDICATIONS & USAGE SECTION
Bronchitis-Asthma Formulated for symptoms associated with bronchitis, pneumonia, asthma, croup and other respiratory system conditions.
DOSAGE & ADMINISTRATION SECTION
Directions: Ages 12 and up, take 6 pellets orally (ages 0 to 11, give 3 pellets) one to four times daily or as directed by a healthcare professional. Under age 2, crush or dissolve pellets in purified water.
ACTIVE INGREDIENT SECTION
Active Ingredients: Influenzinum 30x, Antimon. tart. 15x, Arsenicum alb. 15x, Bryonia 15x, Camphora 15x, Chelidonium majus 15x, Cinchona 15x, Drosera 15x, Eucalyptus 15x, Hepar sulph. calc. 15x, Histaminum hydrochloricum 15x, Ipecac. 15x, Kali bic. 15x, Kali carb. 15x, Kali iod. 15x, Lycopodium 15x, Myrrha 15x, Natrum sulphuricum 15x, Nux vom. 15x, Phosphorus 15x, Pulsatilla 15x, Sanguinaria 15x, Spongia 15x, Stannum met. 15x, Tussilago farfara 15x, Verbascum 15x, Echinacea 3x, Lappa 3x, Rumex crisp. 3x.
INACTIVE INGREDIENT SECTION
Inactive Ingredients: Gluten-free, non-GMO, beet-derived sucrose pellets.
PURPOSE SECTION
Formulated for symptoms associated with bronchitis, pneumonia, asthma, croup and other respiratory system conditions.
QUESTIONS? SECTION
www.newtonlabs.net Newton Laboratories, Inc. FDA Est # 1051203 - Conyers, GA 30012
Questions? 1.800.448.7256
WARNINGS SECTION
Warning: Do not use if tamper- evident seal is broken or missing. Consult a licensed healthcare professional if pregnant, nursing of if symptoms worsen or persist for more than a few days. Keep out of reach of children.
PREGNANCY OR BREAST FEEDING SECTION
Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days.
KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children
PACKAGE LABEL
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Antimony Potassium Tartrate | ACTIVE INGREDIENT | DL6OZ476V3 | 1 | |
| Arctium Lappa Root | ACTIVE INGREDIENT | 597E9BI3Z3 | 1 | |
| Arsenic Trioxide | ACTIVE INGREDIENT | S7V92P67HO | 1 | |
| Bryonia Alba Root | ACTIVE INGREDIENT | T7J046YI2B | 1 | |
| Calcium Sulfide | ACTIVE INGREDIENT | 1MBW07J51Q | 1 | |
| Camphor (natural) | ACTIVE INGREDIENT | N20HL7Q941 | 1 | |
| Chelidonium Majus | ACTIVE INGREDIENT | 7E889U5RNN | 1 | |
| Cinchona Officinalis Bark | ACTIVE INGREDIENT | S003A158SB | 1 | |
| Drosera Rotundifolia | ACTIVE INGREDIENT | QR44N9XPJQ | 1 | |
| Echinacea, Unspecified | ACTIVE INGREDIENT | 4N9P6CC1DX | 1 | |
| Eucalyptus Globulus Leaf | ACTIVE INGREDIENT | S546YLW6E6 | 1 | |
| Histamine Dihydrochloride | ACTIVE INGREDIENT | 3POA0Q644U | 1 | |
| Influenza A Virus | ACTIVE INGREDIENT | R9HH0NDE2E | 1 | |
| Influenza B Virus | ACTIVE INGREDIENT | 1314JZ2X6W | 1 | |
| Ipecac | ACTIVE INGREDIENT | 62I3C8233L | 1 | |
| Lycopodium Clavatum Spore | ACTIVE INGREDIENT | C88X29Y479 | 1 | |
| Myrrh | ACTIVE INGREDIENT | JC71GJ1F3L | 1 | |
| Phosphorus | ACTIVE INGREDIENT | 27YLU75U4W | 1 | |
| Potassium Carbonate | ACTIVE INGREDIENT | BQN1B9B9HA | 1 | |
| Potassium Dichromate | ACTIVE INGREDIENT | T4423S18FM | 1 | |
| Potassium Iodide | ACTIVE INGREDIENT | 1C4QK22F9J | 1 | |
| Pulsatilla Vulgaris | ACTIVE INGREDIENT | I76KB35JEV | 1 | |
| Rumex Crispus Root | ACTIVE INGREDIENT | 9N1RM2S62C | 1 | |
| Sanguinaria Canadensis Root | ACTIVE INGREDIENT | N9288CD508 | 1 | |
| Sodium Sulfate | ACTIVE INGREDIENT | 0YPR65R21J | 1 | |
| Spongia Officinalis Skeleton, Roasted | ACTIVE INGREDIENT | 1PIP394IID | 1 | |
| Strychnos Nux-vomica Seed | ACTIVE INGREDIENT | 269XH13919 | 1 | |
| Tin | ACTIVE INGREDIENT | 387GMG9FH5 | 1 | |
| Tussilago Farfara | ACTIVE INGREDIENT | 0JXZ63016V | 1 | |
| Verbascum Thapsus | ACTIVE INGREDIENT | C9TD27U172 | 1 | |
| Antimony Cation (3+) | ACTIVE MOIETY | 069647RPT5 | 1 | |
| Arctium Lappa Root | ACTIVE MOIETY | 597E9BI3Z3 | 1 | |
| Arsenic Cation (3+) | ACTIVE MOIETY | C96613F5AV | 1 | |
| Bryonia Alba Root | ACTIVE MOIETY | T7J046YI2B | 1 | |
| Calcium Sulfide | ACTIVE MOIETY | 1MBW07J51Q | 1 | |
| Camphor (natural) | ACTIVE MOIETY | N20HL7Q941 | 1 | |
| Carbonate Ion | ACTIVE MOIETY | 7UJQ5OPE7D | 1 | |
| Chelidonium Majus | ACTIVE MOIETY | 7E889U5RNN | 1 | |
| Cinchona Officinalis Bark | ACTIVE MOIETY | S003A158SB | 1 | |
| Dichromate Ion | ACTIVE MOIETY | 9LKY4BFN2V | 1 | |
| Drosera Rotundifolia | ACTIVE MOIETY | QR44N9XPJQ | 1 | |
| Echinacea, Unspecified | ACTIVE MOIETY | 4N9P6CC1DX | 1 | |
| Eucalyptus Globulus Leaf | ACTIVE MOIETY | S546YLW6E6 | 1 | |
| Histamine | ACTIVE MOIETY | 820484N8I3 | 1 | |
| Influenza A Virus | ACTIVE MOIETY | R9HH0NDE2E | 1 | |
| Influenza B Virus | ACTIVE MOIETY | 1314JZ2X6W | 1 | |
| Iodide Ion | ACTIVE MOIETY | 09G4I6V86Q | 1 | |
| Ipecac | ACTIVE MOIETY | 62I3C8233L | 1 | |
| Lycopodium Clavatum Spore | ACTIVE MOIETY | C88X29Y479 | 1 | |
| Myrrh | ACTIVE MOIETY | JC71GJ1F3L | 1 | |
| Phosphorus | ACTIVE MOIETY | 27YLU75U4W | 1 | |
| Pulsatilla Vulgaris | ACTIVE MOIETY | I76KB35JEV | 1 | |
| Rumex Crispus Root | ACTIVE MOIETY | 9N1RM2S62C | 1 | |
| Sanguinaria Canadensis Root | ACTIVE MOIETY | N9288CD508 | 1 | |
| Sodium Sulfate Anhydrous | ACTIVE MOIETY | 36KCS0R750 | 1 | |
| Spongia Officinalis Skeleton, Roasted | ACTIVE MOIETY | 1PIP394IID | 1 | |
| Strychnos Nux-vomica Seed | ACTIVE MOIETY | 269XH13919 | 1 | |
| Tin | ACTIVE MOIETY | 387GMG9FH5 | 1 | |
| Tussilago Farfara | ACTIVE MOIETY | 0JXZ63016V | 1 | |
| Verbascum Thapsus | ACTIVE MOIETY | C9TD27U172 | 1 | |
| Sucrose | INACTIVE INGREDIENT | C151H8M554 | 1 |
Products#
Every source-derived product name is available through these pages.
- Bronchitis - Asthma
- Influenza A Virus, Influenza B Virus, Antimon. tart., Arsenicum alb., Bryonia, Camphora, Chelidonium majus, Cinchona, Drosera, Eucalyptus, Hepar sulph. calc., Histaminum hydrochloricum, Ipecac., Kali bic., Kali carb., Kali iod., Lycopodium, Myrrha, Natrum sulphuricum, Nux vom., Phosphorus, Pulsatilla, Sanguinaria, Spongia , Stannum met., Tussilago farfara, Verbascum, Echinacea, Lappa, Rumex crisp.
- Influenza A Virus
- Antimony Potassium Tartrate
- Antimony Cation (3+)
- Arsenic Trioxide
- Arsenic Cation (3+)
- Bryonia Alba Root
- Camphor (natural)
- Chelidonium Majus
- Cinchona Officinalis Bark
- Drosera Rotundifolia
- Eucalyptus Globulus Leaf
- Calcium Sulfide
- Histamine Dihydrochloride
- Histamine
- Ipecac
- Potassium Dichromate
- Dichromate Ion
- Potassium Carbonate
- Carbonate Ion
- Potassium Iodide
- Iodide Ion
- Lycopodium Clavatum Spore
- Myrrh
- Sodium Sulfate
- Sodium Sulfate Anhydrous
- Strychnos Nux-vomica Seed
- Phosphorus
- Pulsatilla Vulgaris
- Sanguinaria Canadensis Root
- Spongia Officinalis Skeleton, Roasted
- Tin
- Tussilago Farfara
- Verbascum Thapsus
- Echinacea, Unspecified
- Arctium Lappa Root
- Rumex Crispus Root
- Influenza B Virus
- Sucrose
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 55714-4407 | 55714-4407-1, 55714-4407-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Sucrose | SUCROSE | C151H8M554 | TABLET, DELAYED RELEASE / ORAL | 295.33 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SUPPOSITORY / RECTAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | LOZENGE / TRANSMUCOSAL | 1255 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 119.12 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SUSPENSION, EXTENDED RELEASE / ORAL | 5400 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TROCHE / ORAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, COATED / ORAL | 516.42 mg | ||
| Sucrose | SUCROSE | C151H8M554 | WAFER / ORAL | 155.2 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, EXTENDED RELEASE / ORAL | 619 mg | ||
| Sucrose | SUCROSE | C151H8M554 | LIQUID / ORAL | 37500 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, FILM COATED / ORAL | 145 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | 1 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTABLE, LIPOSOMAL / INTRAVENOUS | 7560 mg | ||
| Sucrose | SUCROSE | C151H8M554 | DROPS / ORAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE / ORAL | 3568 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET / ORAL | 4249 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TROCHE / BUCCAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 900 mg | ||
| Sucrose | SUCROSE | C151H8M554 | LOZENGE / BUCCAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | 308 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CONCENTRATE / ORAL | 4800 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SUSPENSION / ORAL | 48209 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SYRUP / ORAL | 46400 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET / SUBLINGUAL | 109 mg | ||
| Sucrose | SUCROSE | C151H8M554 | PASTILLE / ORAL | 426 mg | ||
| Sucrose | SUCROSE | C151H8M554 | POWDER, FOR SOLUTION / ORAL | 38666 mg | ||
| Sucrose | SUCROSE | C151H8M554 | POWDER, FOR SUSPENSION / ORAL | 40017 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS | 9.4 %w/v | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, CHEWABLE / ORAL | 7258 mg | ||
| Sucrose | SUCROSE | C151H8M554 | ELIXIR / ORAL | 18000 mg | ||
| Sucrose | SUCROSE | C151H8M554 | POWDER / ORAL | 27768 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, COATED PELLETS / ORAL | 59.8 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, SOLUTION / INTRAVENOUS | NA | ||
| Sucrose | SUCROSE | C151H8M554 | SOLUTION / RECTAL | 35.42 %w/v | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION / SUBCUTANEOUS | 47.75 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION / INTRAVENOUS | 1950 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 2000 mg | ||
| Sucrose | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | 18790 mg | ||
| Sucrose | SUCROSE | C151H8M554 | GRANULE, FOR SOLUTION / ORAL | 42596 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SUSPENSION/ DROPS / ORAL | 3750 mg | ||
| Sucrose | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION / ORAL | 31885 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET / BUCCAL | 109 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SOLUTION / ORAL | 70000 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 86 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, EMULSION / INTRAVENOUS | 970 mg | ||
| Sucrose | SUCROSE | C151H8M554 | GRANULE / ORAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, DELAYED RELEASE / ORAL | 955 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, EXTENDED RELEASE / ORAL | 284.54 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 98e5c93f-58d9-5d90-e053-2a95a90aec06 | 0cbaeada-a536-d27f-0d9d-487ce8f93944 | 2019-12-04 | Warnings | 0cbaeada-a536-d27f-0d9d-487ce8f93944 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
